Literature DB >> 9820580

Identification of a 25-aminoacid sequence from the major African swine fever virus structural protein VP72 recognised by porcine cytotoxic T lymphocytes using a lipoprotein based expression system.

A Leitão1, A Malur, P Cornelis, C L Martins.   

Abstract

Identification of African swine fever virus (ASFV) proteins recognised by cytotoxic T lymphocytes (CTL) from swine surviving ASFV/NH/P68 infection was assessed using expression vectors based on the Pseudomonas aeruginosa outer membrane lipoprotein I gene (oprI). Viral antigens expressed as fusion lipoproteins were shown to be taken efficiently by porcine blood-derived macrophages incubated with outer membrane protein preparations from transformed E. coli. To assess recognition by CTL the fusion lipoprotein-treated macrophages were used as targets in 51Cr release microcytotoxicity assays. Using this approach it was shown that the aminoacid sequence HKPHQSKPILTDENDTQRTCSHTNP from the major structural ASFV protein (VP72), encoded by a recombinant clone (pVUB72) is presented by macrophages, which are lysed under restriction of SLA class I antigens. Overall, the results demonstrate that the oprI based vectors are valuable tools to study ASFV-specific CTL activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9820580     DOI: 10.1016/s0166-0934(98)00105-0

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  15 in total

1.  An outbreak of African Swine Fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa.

Authors:  S O Odemuyiwa; I A Adebayo; W Ammerlaan; A T Ajuwape; O O Alaka; O I Oyedele; K O Soyelu; D O Olaleye; E B Otesile; C P Muller
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Recombinant Newcastle disease virus expressing African swine fever virus protein 72 is safe and immunogenic in mice.

Authors:  Xinxin Chen; Jifei Yang; Yanhong Ji; Edward Okoth; Bin Liu; Xiaoyang Li; Hong Yin; Qiyun Zhu
Journal:  Virol Sin       Date:  2016-03-11       Impact factor: 4.327

4.  Induction of Robust Immune Responses in Swine by Using a Cocktail of Adenovirus-Vectored African Swine Fever Virus Antigens.

Authors:  Shehnaz Lokhandwala; Suryakant D Waghela; Jocelyn Bray; Cameron L Martin; Neha Sangewar; Chloe Charendoff; Rashmi Shetti; Clay Ashley; Chang-Hsin Chen; Luc R Berghman; Duncan Mwangi; Paul J Dominowski; Dennis L Foss; Sharath Rai; Shaunak Vora; Lindsay Gabbert; Thomas G Burrage; David Brake; John Neilan; Waithaka Mwangi
Journal:  Clin Vaccine Immunol       Date:  2016-11-04

Review 5.  African swine fever vaccines: a promising work still in progress.

Authors:  Laia Bosch-Camós; Elisabeth López; Fernando Rodriguez
Journal:  Porcine Health Manag       Date:  2020-07-02

6.  Identification and Immunogenicity of African Swine Fever Virus Antigens.

Authors:  Christopher L Netherton; Lynnette C Goatley; Ana Luisa Reis; Raquel Portugal; Rachel H Nash; Sophie B Morgan; Lynden Gault; Raquel Nieto; Veronica Norlin; Carmina Gallardo; Chak-Sum Ho; Pedro J Sánchez-Cordón; Geraldine Taylor; Linda K Dixon
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

7.  The low-virulent African swine fever virus (ASFV/NH/P68) induces enhanced expression and production of relevant regulatory cytokines (IFNalpha, TNFalpha and IL12p40) on porcine macrophages in comparison to the highly virulent ASFV/L60.

Authors:  S Gil; N Sepúlveda; E Albina; A Leitão; C Martins
Journal:  Arch Virol       Date:  2008-09-12       Impact factor: 2.574

8.  DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies.

Authors:  Jordi M Argilaguet; Eva Pérez-Martín; Miquel Nofrarías; Carmina Gallardo; Francesc Accensi; Anna Lacasta; Mercedes Mora; Maria Ballester; Ivan Galindo-Cardiel; Sergio López-Soria; José M Escribano; Pedro A Reche; Fernando Rodríguez
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

Review 9.  Targeting TLR2 for vaccine development.

Authors:  Afonso P Basto; Alexandre Leitão
Journal:  J Immunol Res       Date:  2014-06-26       Impact factor: 4.818

Review 10.  Approaches and Perspectives for Development of African Swine Fever Virus Vaccines.

Authors:  Marisa Arias; Ana de la Torre; Linda Dixon; Carmina Gallardo; Ferran Jori; Alberto Laddomada; Carlos Martins; R Michael Parkhouse; Yolanda Revilla; Fernando And Jose-Manuel Rodriguez
Journal:  Vaccines (Basel)       Date:  2017-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.